855 citations
,
June 2009 in “The Journal of Clinical Endocrinology & Metabolism”
The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.
People discussed their experiences with hair loss medications like finasteride and minoxidil affecting fertility. Some had successful pregnancies while on these medications, others took breaks from the medications when trying to conceive, and there were mixed opinions on the necessity of stopping treatment for conception and pregnancy.
The user is experiencing erectile dysfunction and decreased sperm quality from using Dutasteride for hair loss and is considering stopping it to improve fertility. They are exploring other treatments like Viviscal Men, Minoxidil, Revlan Red System, Fluridil, Nizoral, Stemoxydine, and Eucapil.
A 28-year-old male is concerned about hair loss and is considering starting oral minoxidil now and finasteride after having more children due to fertility concerns. He is worried about losing more hair if he waits four years to begin treatment.
Concerns about the impact of hair loss treatments like finasteride on fertility and future children. The user is worried about reduced sperm count and quality due to lowered DHT levels.
Dutasteride treatment may decrease sperm concentration, but levels remain above WHO recommendations and recover after discontinuation. The study has limitations, including small sample size and lack of pre-treatment sperm data, and does not assess other fertility factors.